Dr. James T. Lin, MD

Dr. Lin practices at St. Charles Surgical Center in Thousand Oaks, California.

Dr. Lin's NPI, 1821009580, was assigned on August 10, 2006. Dr. Lin graduated from Chicago Medical School at Rosalind Franklin University of Medicine and Science in 2000. Dr. Lin holds California license A86869.

Dr. Lin's primary practice is St. Charles Surgical Center, at 550 St Charles Drive, Suite #101, Thousand Oaks, CA 91360. The practice phone is (805) 719-6611.

Dr. Lin's primary practice is St. Charles Surgical Center in Thousand Oaks, California. Dr. Lin is also affiliated with Los Robles Regional Medical Center. Dmand AI also links Dr. Lin to 1 more physician office and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lin practices, 4 sites in all. Vendor and product names are available with a free account.

Anesthesiology is Dr. Lin's primary specialty in the NPI Registry, under taxonomy code 207L00000X. Dr. Lin is board certified in anesthesiology by the American Board of Anesthesiology. Dmand AI has Dr. Lin's licenses on file in 2 states: California and Illinois.

Dmand AI lists back pain injection, lower back pain, muscle pain, fibromyalgia, and limb pain, neck pain and spine problems and thoracic spine disorders among the conditions Dr. Lin treats.

CMS data shows 11,423 Medicare services from Dr. Lin across 32 procedure codes in 2024, for 640 Medicare patients. Medicare paid $730,813 for them.

CMS counts 640 Medicare patients who saw Dr. Lin in 2024. The largest group is 65 to 74, with 258 patients. 75% of them have arthritis, and 75% have high blood pressure. 22% are also on Medicaid. Their average risk score is 1.62, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Lin's median patient age at 71, with 61% women.

In 2024, Dr. Lin wrote 2,835 Medicare Part D claims for 365 patients. 89% of them were for generic drugs. CMS names the drug for 2,658 of them, across 47 drugs with 11 or more claims each, at $275,584 in total drug cost. In 2023, CMS named 3,154 claims across 54 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 55 out of 100 for Dr. Lin for performance year 2024, reported individually. Dr. Lin accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Lin as offering telehealth.

CMS Open Payments shows 1,551 general payments to Dr. Lin from 65 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 90% of the total. Abbvie Inc. paid the most, $1,871.

Dmand AI lists 1 award for Dr. Lin, most recently CMS Stage 1 EHR in 2013.

Dr. Lin graduated from Chicago Medical School at Rosalind Franklin University of Medicine and Science in 2000.

Dr. Lin is in network with 1 carrier, including CMS Medicare. Medicare plans come from the most carriers, 1. Check the plan with the practice before a visit.